Search

everythinglearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Lower SMAD2/3 activation predicts more severe skin cancer.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

TPA is about 50 times more effective at promoting tumors than MZ.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Low SHBG levels are linked to negative health outcomes and should be used in assessing and managing health conditions.

Patients with thyroid disorders show different symptoms and antibody levels.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Trichoblastic fibroma and basal cell carcinoma are similar but different from trichoepithelioma.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Consider rare forms of CAH for accurate diagnosis and treatment.

A new method can measure stress levels in pregnant women using hair samples.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

The cat had a pituitary tumor causing hormone imbalance and related health issues.